Zydus Lifesciences has received the EIR report from the United States Food and Drug Administration (USFDA) for the inspection conducted at its transdermal patch manufacturing facility located at Pharmez, Ahmedabad. This facility underwent an inspection from July 15 to 19, 2024 and has been classified as Voluntary Action Indicated (VAI).
Zydus Lifesciences (formerly known as Cadila Healthcare) is an India-based pharmaceutical company.